COST PLUS DRUGS Trademark

Trademark Overview

On Friday, March 11, 2022, a trademark application was filed for COST PLUS DRUGS with the United States Patent and Trademark Office. The USPTO has given the COST PLUS DRUGS trademark a serial number of 97307445. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, November 5, 2024. This trademark is owned by Mark Cuban Cost Plus Drug Company, PBC. The COST PLUS DRUGS trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a full line of pharmaceutical preparations
cost plus drugs

General Information

Serial Number97307445
Word MarkCOST PLUS DRUGS
Filing DateFriday, March 11, 2022
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, November 5, 2024
Registration Number0000000
Registration DateTuesday, November 26, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesHouse mark for a full line of pharmaceutical preparations
NOT AVAILABLE"DRUGS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 16, 2022
Primary Code005
First Use Anywhere DateTuesday, April 30, 2024
First Use In Commerce DateTuesday, April 30, 2024

Trademark Owner History

Party NameMark Cuban Cost Plus Drug Company, PBC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLittleton, CO 80123

Trademark Events

Event DateEvent Description
Tuesday, March 15, 2022NEW APPLICATION ENTERED
Wednesday, March 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 22, 2022ASSIGNED TO EXAMINER
Wednesday, December 28, 2022NON-FINAL ACTION WRITTEN
Wednesday, December 28, 2022NON-FINAL ACTION E-MAILED
Wednesday, December 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 28, 2023SUSPENSION LETTER WRITTEN
Friday, April 28, 2023LETTER OF SUSPENSION E-MAILED
Friday, April 28, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 12, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, February 12, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, November 15, 2023FINAL REFUSAL WRITTEN
Wednesday, November 15, 2023FINAL REFUSAL E-MAILED
Wednesday, November 15, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, May 9, 2024USE AMENDMENT FILED
Monday, May 13, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, October 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 9, 2024TEAS AMENDMENT OF USE RECEIVED
Monday, May 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 20, 2024AMENDMENT TO USE PROCESSING COMPLETE
Friday, September 20, 2024ASSIGNED TO LIE
Tuesday, October 29, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 29, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, October 29, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, October 22, 2024USE AMENDMENT ACCEPTED
Wednesday, October 30, 2024APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Related Keywords

drugs plus cost pharmaceutical preparations line full mark house